Welcome to the ePoster Viewing Panel of AICOG 2025

Jio World Convention Center, Mumbai
Go back

Title: DYSGERMINOMA MASQUERADING AS NEOPLASTIC LESION: A DIAGNOSTIC DILEMMA

e-poster Number: EP 247

Category: Gynaecologic Oncology
Author Name: Dr. Chaithra P A
Institute: Esic medical College and hospital KALABURAGI
Co-Author Name:
Abstract :
ABSTRACT : Presenter: Dr. Chaithra.P.A Moderator:Dr. Rajesh Tile Department of OBG ESIC MCH,KALABURAGI Title: Dysgerminoma Masquerading as Neoplastic Lesion. ?A diagnostic dilemma? Introduction: Ovarian germ cell tumors are derived from primordial germ cells of the ovary. They may be benign or malignant and compromise about 30% of ovarian neoplasms and 3% of all malignant ovarian neoplasms. They arise in young women between 10 and 30 years of age. These tumors grow rapidly ,and present with large ovarian mass with early stage disease Case study 32 years P2L2 with previous 2 LSCS with c/o abdominal pain since 2 years dull aching type on examination mass of 20?15cm with p/v uterus corresponding to 24 weeks with forniceal fullness USG done and suggestive of large neoplastic lesion and CT scan shows right sided malignant solid ovarian tumor (10?15?17cm) Diagnosis of neoplastic lesion was made and patient was taken for exploratory laparotomy Laparotomy revealed lobulated right ovarian mass approximately 15?10?12 cm with omental adhesions noted between peritoneum and anterior abdominal wall. Postoperatively patient was stable and advised to be followed up regularly with LDH,B hcg and MRI . Conclusion The careful surgical staging,conservative surgery for unilateral disease,followed by adjuvant chemotherapy seems to be ideal management in cases of ovarian dysgerminoma. Reference Williams gynaecology 4th edition Otto K, Ebertz O, Matsingou C, Andrikos D, De Wilde RL, Krentel H. Ovarian Dysgerminoma - Challenging Presurgical Diagnosis and Mini-Mally Invasive Treatment. Arch Clin Med Case Rep. 2023;7(1):66-69. doi: 10.26502/acmcr.96550573. Epub 2023 Feb 3. PMID: 36873804; PMCID: PMC9979950.